Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
T. Troosters (Leuven, Belgium), ML. Nici (Providence, USA), W. Janssens (Leuven, Belgium), M. Vittacca (Gussago, Italy). ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme. ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme

Member's Comments

No comment yet.

Related content which might interest you: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment Year: 2020 ERS/ATS joint webinar: Rehabilitation after COVID 19 disease Source: ERS webinar 2020: ERS/ATS joint webinar: Rehabilitation after COVID 19 disease Year: 2020 Diagnosis and treatment of COVID-19 Source: Webinar 2020: Diagnosis and treatment of COVID-19 Year: 2020 SARS-CoV-2 (COVID-19): Research response Source: Webinar 2020: SARS-CoV-2 (COVID-19): research response Year: 2020 COVID-19: Q and A Source: ERS Webinar 2020: COVID-19: Q and A Year: 2020 Health Policy of COVID-19 management Source: ERS Webinar 2020: Health Policy of COVID-19 management Year: 2020 Perspectives of the management of COVID-19 infection in China Source: Webinar 2020: Perspectives of the management of COVID-19 infection in China Year: 2020 Update on respiratory virus research and clinical care including influenza outbreak 2017-18, SARS, MERS and other respiratory pathogens Source: International Congress 2018 – PG3 How to plan for and manage a respiratory epidemic/pandemic Year: 2018 Coronavirus disease: outbreak in China and globally Source: Webinar 2020 Year: 2020 Interview on Coronavirus COVID-19 management experience in China Source: Webinar 2020: Interview on Coronavirus COVID-19 management experience in China Year: 2020 Human metapneumovirus and community-acquired pneumonia: a pediatric survey Source: Annual Congress 2005 - New insights in respiratory infections in children Year: 2005 The comaprison of clinical characteristics and courses of pediatric patients hospitalized with pandemic influenza A (H1N1) and seasonal influenza in Korea from 2009-2011 Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children Year: 2014 A nosocomial outbreak of influenza during a period without influenza epidemic activity Source: Eur Respir J 2003; 21: 303-307 Year: 2003 Epidemic and pandemic viral infections: impact on tuberculosis and the lung Source: Eur Respir J, 56 (4) 2001727; 10.1183/13993003.01727-2020 Year: 2020 Rapid spread of the novel respiratory syncytial virus A ON1 genotype, during the epidemic seasons 2011-2013 Source: International Congress 2014 – Virus-triggered lower respiratory disease in children Year: 2014 Can procalcitonin (PCT) be an indicator of viral severe community-acquired pneumonia (CAP) based on epidemics of influenza H1N1 in season 2015-2016? Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016 Clinical features of influenza virus infection of 2013/2014 season Source: International Congress 2015 – Viral infections: basic research and clinical perspective Year: 2015 Late-breaking abstract: Prevalence of influenza A H1N1 virus infection in patients with asthmatic crisis of the National Institute of Respiratory Diseases (in Mexico City) Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011 RSV and human metapneumovirus – major pathogens of childhood – also adults and the elderly? Source: Annual Congress 2005 - Major viral threats to the lung Year: 2005 Radiological findings and correlation to clinical outcome in patients admitted due to influenza A (H1N1) infection Source: Annual Congress 2013 –Viral infections Year: 2013